Immunome Appoints Sandra M. Swain to Board of DirectorsBusiness Wire • 7 days agoImmunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the appointment of Sandra M. Swain, M.D., to...